The development of NSCLC is driven by genetic mutation, the most important of which are those in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) genes (Gridelli et al. 2015). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.